Astonea Labs IPO Allotment Status

Astonea Labs Ltd, incorporated in 2017, is engaged in contract manufacturing of pharmaceutical and cosmetic products for companies both within India and internationally. The Astonea Labs IPO comes with a total issue size of ₹37.67 crore, comprising entirely a fresh issue of 27.90 lakh shares. The IPO opened on May 27, 2025, and closed on May 29, 2025. The allotment date for the Astonea Labs IPO is expected to be finalised on Friday, May 30, 2025.

Don’t Miss Out on the Next Big IPO – Invest With Just a Few Clicks!

Open Account Now

Steps to Check Astonea Labs IPO Allotment Status on Registrar Site

• Visit Kfin Technologies Limited's website
• Select "Astonea Labs IPO" from the dropdown menu on the allotment status page
• Enter your PAN ID, Demat Account Number, or Application Number in the designated field
• Complete the captcha verification process and click on the "Submit" button to view your allotment status

Steps to Check Astonea Labs IPO Allotment Status on BSE

• Navigate to the BSE SME IPO Allotment Status Page
• Choose "Astonea Labs IPO" from the list of active IPOs in the dropdown menu
• Input your Application Number and PAN ID in the required fields
• Verify the captcha and click "Search" to check your allotment status

Astonea Labs IPO Subscription Status

Astonea Labs' IPO received moderate investor interest, being subscribed 1.79 times overall. Here is a category-wise breakdown of the subscription as of 5:24:33 PM on May 29, 2025:

• Retail Category: 1.69 times
• Qualified Institutional Buyers (QIB): 0.70 times
• Non-Institutional Investors (NII): 5.60 times

Utilization of IPO Proceeds

The funds raised through the IPO will be utilised as follows:

• International Registration: Funding of expenses proposed to be incurred towards registration in Bolivia, South America
• Plant and Machinery: Purchase and installation of plant and machinery for ointment production for export by international standards
• Marketing: Advertising, marketing and brand building
• Technology: Investment in procuring hardware and software
• Working Capital: Funding of working capital requirements
• General Corporate Purposes: Supporting various business initiatives

Business Overview

The company manufactures and markets a variety of pharmaceutical and cosmetic products, including antibiotics, anti-cold medicines, antihistamines, and treatments for diabetes, heart, gynaecological issues, infections, and more. Astonea Labs offers skin, tooth, and hair care products in forms like gels, creams, and serums, and also trades packaging and raw materials for the pharmaceutical and cosmetic industries, meeting industry standards. The company markets its brands "Glow Up" skincare and "Regero" pharma products, and plans to launch "Avicel," with exports to countries like Iraq and Yemen, supported by a team of 217 employees as of August 16, 2024.